Twin Tree Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.65M Buy
46,600
+1,500
+3% +$102K 0.07% 372
2026
Q1
$2.91M Buy
+45,100
New +$3.18M 0.06% 359
2025
Q3
Sell
-17,600
Closed -$916K 1614
2025
Q2
$916K Buy
+17,600
New +$1M ﹤0.01% 1371
2025
Q1
Sell
-3,000
Closed -$143K 1701
2024
Q4
$143K Buy
+3,000
New +$154K ﹤0.01% 1406
2021
Q3
Sell
-5,900
Closed -$268K 1655
2021
Q2
$268K Buy
+5,900
New +$261K ﹤0.01% 1166

Other funds holding HALO

Twin Tree Management's HALO Position: Q2 2026 in Review

Twin Tree Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 10,248 shares — an estimated $699K sold.

Twin Tree Management first reported a position in HALO in Q4 2020 and held it in 12 quarters. The position peaked at $1.96M in Q4 2022. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Twin Tree Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Twin Tree Management sold 10,248 Halozyme shares in Q2 2026, an estimated $699K.
  • Twin Tree Management first reported a position in Halozyme in Q4 2020 and held it in 12 quarters.
  • Twin Tree Management's Halozyme position peaked at $1.96M in Q4 2022.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Twin Tree Management's 13F filing for Q2 2026, filed 12 Aug 2026.